The results showed a significant positive correlation between BTN2A2 and immune checkpoint gene expression (Figure 8A–8D), thereby indicating the significance of BTN2A2 in the immunotherapy of glioma. The gene discussed is BTN2A2; the disease is central nervous system cancer.